Omics-Insights: Your Weekly Genomics & Proteomics Digest
Greetings, Omics Enthusiasts!
Welcome to our latest Omics Newsletter, your portal to the freshest updates and innovations in genomics. This week's highlights include Patient Square Capital's snag of NanoString Technologies, Inc., Vizgen's legal win against 10x Genomics, and BioSkryb Genomics' game-changing ResolveDNA and ResolveOME kits shaking up single-cell multiomics research. Alithea Genomics scores seed funding, while Curio Bioscience unveils Curio Trekker, set to revolutionize cancer biology and neuroscience research. Oxford Nanopore Technologies and SeqOne join forces for clinical variant interpretation, aiming to boost diagnostic accuracy. Plus, in our Spotlight, Danae Van Oene steps into the role of Senior VP of Global Sales and Support at Element Biosciences, signaling the company's global expansion drive. Check out live Omics roles at Kinetica and snag some job-hunting tips to ace the competitive market. Stay tuned for more groundbreaking insights in Omics!
This week's latest news in the field of Omics:
Patient Square Capital, a prominent investment firm in the healthcare sector, has reached an agreement to purchase NanoString Technologies, Inc., a leading provider of Spatial Biology tools for research. Acting as the initial bidder in a court-monitored sale process, Patient Square will acquire nearly all global business assets of NanoString for $220 million. This acquisition, facilitated under Section 363 of the Bankruptcy Code, is subject to approval by the Bankruptcy Court and adherence to bidding procedures. NanoString's CEO, Brad Gray, expressed confidence in the partnership, emphasizing its role in maintaining operational continuity and supporting the company's innovative goals.
Vizgen Victorious as PTAB Rejects 10x Genomics IPR Petition
Vizgen celebrates a significant legal victory as the Patent Trial and Appeal Board (PTAB) denies 10x Genomics' petition for Inter Partes Review (IPR) concerning a patented technology licensed from Harvard University. The PTAB cited deficiencies in 10x's petition, emphasizing the lack of evidence to support its claims. This decision reinforces Vizgen's position and underscores the value of its innovations in spatial biology. CEO Terry Lo sees this outcome as validation of their patent's scientific merit and pledges to continue advancing genomic science for the betterment of human health.
BioSkryb Genomics Launches Revolutionary ResolveDNA and ResolveOME Kits
BioSkryb Genomics introduces a groundbreaking advancement in single-cell multiomics research with the launch of ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core Kits. These innovative kits leverage primary template-directed amplification, offering efficient workflows and unparalleled insights into single-cell DNA. The ResolveOME kit integrates DNA and RNA seamlessly from every cell, streamlining processes and enabling comprehensive multiomic analysis. Powered by the BaseJumper platform, BioSkryb's solutions empower researchers to unlock the full potential of single-cell multiomics with unprecedented ease and precision.
Alithea Genomics Raises CHF 2.8M in Seed Financing
Alithea Genomics, a Swiss RNA analysis company, secures CHF 2.8 million in additional seed financing led by Novalis Biotech and new investor TechU Ventures. The company plans to utilize the funds to expand manufacturing capacity, develop new technologies, and establish a US subsidiary. Alithea's proprietary bulk RNA barcoding and sequencing technology, commercialized from EPFL, continues to gain traction, with recent advancements including the introduction of Drug-seq for pharmaceutical applications.
Curio Bioscience Unveils Curio Trekker, Enabling Single-Cell Spatial Data
Curio Bioscience launches Curio Trekker, a product based on Slide-tags, developed by researchers at the Broad Institute, facilitating the conversion of single-cell genomics data into spatial data. This innovation marks a transformative leap in scientific discovery, offering researchers the ability to capture spatial context alongside single-cell transcriptomes. By providing true single-cell spatial resolution, Curio Trekker promises to revolutionize research in areas such as cancer biology and neuroscience. Early-access customers praise its ease of implementation and high spatial resolution, foreseeing significant contributions to molecular understanding and patient care.
Oxford Nanopore Technologies and SeqOne Partner for Clinical Variant Interpretation
Oxford Nanopore Technologies collaborates with SeqOne to support variant interpretation from whole-genome nanopore sequencing data for clinical use. This partnership aims to develop analytical workflows, initially focusing on rare diseases and subsequently expanding to oncology. SeqOne's GermVar software, available on Oxford Nanopore's Epi2Me platform, aids in interpreting whole-genome variants, with plans for further applications in cancer predisposition and somatic analysis. Additionally, SeqOne launches a global research partnership program leveraging Oxford Nanopore's adaptive sampling to enhance diagnostic yield and patient care.
Spotlight: Person of the Week - Danae Van Oene
Element Biosciences Appoints Danae Van Oene as Senior Vice President of Global Sales and Support
Element Biosciences, Inc., a leading developer of innovative scientific technologies, proudly announces the appointment of Danae Van Oene as Senior Vice President of Global Sales and Support.
In her new capacity, Danae will lead Element's commercial sales endeavours, overseeing regions spanning North America, Asia Pacific, EMEA, Latin America, and other global markets. With Element's expanding international customer base in focus, Danae will collaborate closely with customers and distributors worldwide to optimize operational efficiency and integrate customer feedback into product enhancements.
Molly He, PhD, CEO, and co-founder of Element Biosciences, expressed confidence in Danae's pivotal role in fortifying global presence and fostering customer relationships. Danae brings a wealth of experience, having served as Vice President and General Manager for the Americas region at 10x Genomics, where she also led global sales programs and strategic partnerships.
领英推荐
Prior to her tenure at 10x Genomics, Danae held key sales management positions at Illumina and served as Distribution Territory Manager for Beckman Coulter. Danae Van Oene expressed enthusiasm for driving Element's commercialization efforts, leveraging the company's current successes and planned innovations to empower laboratories worldwide. With a keen awareness of the rapidly evolving scientific landscape, Danae is poised to contribute to the advancement of biology and scientific discovery.
Current Live Omics Roles at Kinetica:
Europe:
Global Product Manager – Genomic Platforms – Europe
Field Application Specialist – Genomics Platforms – UK
Machine Learning Engineer – NGS Platforms – Europe
North America:
Sales Executive – AI Imaging Software - West Coast
Sales Executive – AI Imaging Software – Mid-West
Sales Executive – NGS Software – US
VP of Product Management – Life Science Instruments
Account Manager – Mid-Atlantic – Genomics reagents.
Business Development Manager - Synthetic Biology – West Coast
Business Development Manager - Synthetic Biology – East Coast
Job Hunting Tips from an Omics Specialist Recruiter: Know Your Niche
As a specialist, it's crucial to understand the specific area in which you specialize, whether it's genomics, proteomics, metabolomics, or others. By recognizing your niche, you can tailor your job search to positions that align perfectly with your expertise. This targeted approach increases the likelihood of finding roles that not only match your skills but also provide opportunities for growth and advancement within your field. Remember, a focused job search can lead to greater career satisfaction and success. These insights come from an experienced omics specialist recruiter who understands the importance of knowing your niche in the competitive job market.
Wrapping Up Another Omics-Insights:
Thank you for embarking on a journey into the dynamic world of Omics with Kinetica! Explore the latest genomics job opportunities, stay informed with industry news, and indulge in insightful blogs at www.kinetica.co.uk. Your curiosity drives my commitment to relevant content, and I'm here to provide insights that fuel your scientific endeavors. Feel free to reach out with any questions or feedback. Wishing you ongoing inspiration and discovery in your scientific pursuits. Until next week, may your experiments yield groundbreaking results, and may your Omics journey remain as fascinating as the science itself!